Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Placebo associated with improvement and side effects in treatment of BPH

April 16, 1997

GG-745 compared to finasteride in BPH patients

April 15, 1997

Furosemide vs. placebo for nocturnal polyuria

April 15, 1997

Initial clinical results with vinpocetine for urge incontinence

April 15, 1997

Mechanism of impaired erection with finasteride elucidated

April 15, 1997

Development of Auriculin suspended

April 14, 1997

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

Synthelabo reports agents for urinary incontinence

April 11, 1997

GelTex reports preliminary phase IIc results for RenaGel

April 10, 1997

Urologix's PMA for T3 System accepted for review

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...